Advances in Molecular Subtype-Based Precision Therapy and Strategies to Overcome Resistance in Breast Cancer
Breast cancer is a leading cause of cancer -related morbidity and mortality, characterized by significant biological and molecular heterogeneity. Molecular subtypes —including luminal A, luminal B, HER2 - enriched, and triple -negative—inform prognosis and guide prec ision therapies. Despite advances with endocrine age...